Matching Pairs Diabetes Oral MedsOnline version NUr115 Oral Diabetic Agents by Concetta Fiorentino 1 Enhances glucose-dependent insulin secretion. 2 Inhibit production of glucose by the liver. 3 Do not increased insulin secretion. 4 Possible side-effect of impaired platelet function. 5 Prevents kidneys from reabsorbing glucose. 6 Drug to drug interaction with NSAIDS. 7 Usually given once a day. 8 Increase and prolong the action of the hormone that increases insulin release and decreases glucagon levels. 9 Stimulate beta cells of the pancreas. 10 Sensitize body tissue to insulin: stimulates insulin receptor sites. 11 Stimulate pancreas to secrete insulin. Thiazolidinediones (pioglitazone (actos, rosiglitazone/Avandia) Second generation sulfonylureas (glipizide (Glucotrol) Glyburide (DiaBeta) Glimepiride (Amaryl) Dipeptidyl Pepidase-4 Inhibitors (sitagliptin/Januvia, vildagliptin /Galvus) Sodium-glucose co-transporter 2 inhibitors (empagliflozin/Jardiance Glucagon-like peptide-1 agonist (liraglutide/Victoza,, dulaglutide/Trulicity) Avandia Alpha-glucosidase inhibitors (acarbose/Precose, miglitol (Glyset) Biguanides (metformin (Glucophage) Metformin with glyburide (Glucovance) Januvia glipizide Non-sulfonylurea insulin secretagogues (repaglinide/Prandin, nateglinide/Starlix)